Author:
Hosseini Niloufar,Craddock Kenneth J.,Salehi-rad Shabnam,Brennan Shawn,Bailey Denis J.,Brandwein Joseph M.,Porwit Anna
Publisher
Springer Science and Business Media LLC
Subject
Hematology,Histology,Pathology and Forensic Medicine
Reference11 articles.
1. Bain BJ, Gilliland DG, Horny HP et al (2008) Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. In: Swerdlow SH, Campo E, Harris NL (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 68–73
2. Cools J, DeAngelo DL, Gotlib J et al (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348(13):1201–1214
3. Vu HA, Xinh PT, Masuda M et al (2006) FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation. Leukemia 20:1414–1421
4. Walz C, Erben P, Ritter M et al (2011) Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3. Blood 118:2239–2242
5. Kantarjian HM, O’Brien S, Smith TL et al (2000) Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 18:547–561
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献